All Stories

  1. Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): a modified Delphi exercise to identify a core dataset for asthma and COPD studies

    Article • September 2020, European Respiratory Society (ERS)

    Job van Boven

  2. Making sense of cost-effectiveness analyses in respiratory medicine: a practical guide for non-health economists

    Article • European Respiratory Journal, December 2018, European Respiratory Society (ERS)

    Job van Boven

  3. Costly comorbidities of COPD: the ignored side of the coin?

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Job van Boven

  4. Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Professor David Price, Job van Boven

  5. Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study

    Article • Pragmatic and Observational Research, April 2017, Dove Medical Press

    Dr Marc Miravitlles, Professor David Price, Job van Boven, Dermot Ryan

  6. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2016, Dove Medical Press

    Job van Boven